semaglutide and keto diet Optimize Your Health With an Plan Ketogenic Diets for Body Weight

Mix Greek yogurt with garlic, lemon juice, Parmesan cheese, and Italian seasoning

Common Short-term Side Effects The most common side effects occur especially when starting treatment or increasing doses, and include: Weight gain and increased appetite : Often one of the first noticeable effects Mood changes : Including irritability, anxiety, or euphoria Sleep disturbances : Insomnia or changes in sleep patterns Fluid retention : Causing swelling, particularly in the face (moon face) High blood sugar : Can unmask diabetes or worsen existing diabetes Skin changes : Including acne, easy bruising, and delayed wound healing Serious Long-term Side Effects Long-term use or high doses carry an increased risk for more serious complications: Infection Risk : Suppressed immune system increases the risk of bacterial, viral, and fungal infections Serious infections occur in 3-7% of patients on moderate doses over one year This risk may be increased in immunocompromised patients Bone and Muscle Effects : Osteoporosis affects 30-50% of long term corticosteroid therapy patients Avascular necrosis (bone tissue death due to poor blood supply) Muscle weakness and muscle pain Increased fracture risk, especially in spine and hips Heart Complications : High blood pressure Irregular heartbeat Increased risk of heart disease Fluid retention in lower legs Other Serious Effects : Vision problems including cataracts and glaucoma Severe headache Stomach ulcers Liver disease (rare but possible) Worsening mental illness or new symptoms Important Safety Considerations Taking prednisone safely requires awareness of several critical safety considerations and regular monitoring by your healthcare provider

Basic science and clinical research evidence indicates that GLP-1RAs produce direct immunomodulatory actions that function separately from weight loss

Red or dark pink coloration is a particularly concerning sign

After an average of 25 months, the primary composite outcome of CV death, myocardial infarction, stroke, or hospitalization for unstable angina occurred in 13.4% of individuals in the lixisenatide group compared to 13.2% in the placebo group (hazard ratio [HR] 1.02